Science Explorer Interactive view Map
Company · Newtown · United States

Onconova Therapeutics (United States)

onconova.comROR OpenAlex
Research works
50
▼ 77% vs 2013–17
Citations
999
19.8 per fractional work
Top-10% rate
19.7%
record average 16.5%
Open access
32%
world 28%

Not ranked overall: Onconova Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.70× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 0.88× its world share, 0 worksImmunology and Micro…Neuroscience: 2.73× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.38× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.65× its world share, 0 worksChemistryHealth Professions: 0.56× its world share, 0 worksHealth ProfessionsMedicine: 3.26× its world share, 5 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.4×. Every wedge is a field page.

Who are the top researchers at Onconova Therapeutics (United States)?

Ranked on the composite score, Chen Ren lead among researchers whose main affiliation is Onconova Therapeutics (United States).

  1. 1 Chen Ren United States · #1,327,646 worldwide 9 citations · 15 works
All ranked researchers at Onconova Therapeutics (United States)

Which keywords describe research at Onconova Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Prognostic Factors, Hematopoietic Stem Cells, Cancer Therapy, Acute Myeloid Leukemia, AML, Mutation, Apoptosis and Metastatic Breast Cancer.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Prognostic Factors9▲ 38×5 topics
  2. Cancer Therapy7▲ 21×10 topics
  3. Hematopoietic Stem Cells7▲ 133×3 topics
  4. AML6▲ 259×1 topic
  5. Acute Myeloid Leukemia6▲ 259×1 topic
  6. Mutation6▲ 70×3 topics
  7. Apoptosis5▲ 24×4 topics
  8. Metastatic Breast Cancer4▲ 119×2 topics
  9. Breast Cancer4▲ 26×3 topics
  10. Cell Cycle Control3▲ 250×2 topics
  11. CDK4/6 Inhibitors3▲ 373×1 topic
  12. Palbociclib3▲ 373×1 topic
  13. BCR-ABL3▲ 203×1 topic
  14. Imatinib3▲ 203×1 topic
  15. Cell Cycle3▲ 95×2 topics
  16. Regulation3▲ 9.2×3 topics
  17. MDM23▲ 121×1 topic
  18. p533▲ 121×1 topic
  19. Cancer3▲ 3.6×10 topics
  20. Oxidative Stress3▲ 2.8×9 topics
  21. Chemotherapy2▲ 6.8×9 topics
  22. Targeted Therapy2▲ 23×3 topics
  23. Rituximab2▲ 29×3 topics
  24. Clinical Trials2▲ 7.2×4 topics
  25. Therapeutic Targets2▲ 17×3 topics
  26. Antiretroviral Therapy2▲ 16×3 topics
  27. Genomic Instability2▲ 29×2 topics
  28. ALK Inhibitors2▲ 61×1 topic
  29. Drug Resistance2▲ 10×3 topics
  30. EGFR Mutations2▲ 61×1 topic
  31. Cell Death2▲ 15×2 topics
  32. Hepatotoxicity2▲ 43×2 topics
  33. Bystander Effects2▲ 138×1 topic
  34. HIV Infection2▲ 24×1 topic
  35. Integrase Inhibitors2▲ 71×1 topic
  36. Radiation2▲ 138×1 topic
  37. Chronic Lymphocytic Leukemia1▲ 58×1 topic
  38. Genomic Aberrations1▲ 58×1 topic
  39. Medicinal Chemistry1▲ 6.9×4 topics
  40. Tumor Microenvironment1▲ 7.3×5 topics

Which research topics does Onconova Therapeutics (United States) publish most on?

By volume in 2022–2025: PARP inhibition in cancer therapy, Advanced Breast Cancer Therapies, Chronic Lymphocytic Leukemia Research and Lymphoma Diagnosis and Treatment.

PARP inhibition in cance…1PARP inhibition in cancer therapy: 1 fractional worksAdvanced Breast Cancer T…1Advanced Breast Cancer Therapies: 1 fractional worksChronic Lymphocytic Leuk…0Chronic Lymphocytic Leukemia Research: 0 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksAdenosine and Purinergic Signaling: 0 fractional worksRenal function and acid-…0Renal function and acid-base balance: 0 fractional worksGastroesophageal reflux and treatments: 0 fractional worksSkin and Cellular Biology Research: 0 fractional worksCancer, Lipids, and Metabolism: 0 fractional worksPotassium and Related Disorders: 0 fractional works
OncologyPulmonary and Respiratory MedicineGeneticsPathology and Forensic Medicine5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 PARP inhibition in cancer therapy Oncology 1 works
  2. 2 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  3. 3 Chronic Lymphocytic Leukemia Research Genetics 0 works
  4. 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  5. 5 Adenosine and Purinergic Signaling Physiology 0 works
  6. 6 Renal function and acid-base balance Nephrology 0 works
  7. 7 Gastroesophageal reflux and treatments Gastroenterology 0 works
  8. 8 Skin and Cellular Biology Research Cell Biology 0 works
  9. 9 Cancer, Lipids, and Metabolism Cancer Research 0 works
  10. 10 Potassium and Related Disorders Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.2%not open67.8%

World: 28% of research is openly available.

with international co-authors18.4%domestic only81.6%

World: 19% is written across borders.

How has Onconova Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 77% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Newtown

All research institutions in Newtown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.